que se leu este artigo
array:22 [ "pii" => "S0870255123003967" "issn" => "08702551" "doi" => "10.1016/j.repc.2023.08.001" "estado" => "S300" "fechaPublicacion" => "2023-11-01" "aid" => "2247" "copyrightAnyo" => "2023" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Port Cardiol. 2023;42:933" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemAnterior" => array:18 [ "pii" => "S0870255123003931" "issn" => "08702551" "doi" => "10.1016/j.repc.2023.04.016" "estado" => "S300" "fechaPublicacion" => "2023-11-01" "aid" => "2244" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Port Cardiol. 2023;42:931-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Ischemic stroke and homocysteine: To test or not to test?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "931" "paginaFinal" => "932" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "AVC isquémico e homocisteinemia: testar ou não estar?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Laura Guerreiro, Sofia Rosado Julião, Mariana Alves" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Laura" "apellidos" => "Guerreiro" ] 1 => array:2 [ "nombre" => "Sofia" "apellidos" => "Rosado Julião" ] 2 => array:2 [ "nombre" => "Mariana" "apellidos" => "Alves" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255123003931?idApp=UINPBA00004E" "url" => "/08702551/0000004200000011/v1_202311030625/S0870255123003931/v1_202311030625/en/main.assets" ] "asociados" => array:1 [ 0 => array:18 [ "pii" => "S0870255123003931" "issn" => "08702551" "doi" => "10.1016/j.repc.2023.04.016" "estado" => "S300" "fechaPublicacion" => "2023-11-01" "aid" => "2244" "copyright" => "Sociedade Portuguesa de Cardiologia" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Port Cardiol. 2023;42:931-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Ischemic stroke and homocysteine: To test or not to test?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "931" "paginaFinal" => "932" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "AVC isquémico e homocisteinemia: testar ou não estar?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Laura Guerreiro, Sofia Rosado Julião, Mariana Alves" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Laura" "apellidos" => "Guerreiro" ] 1 => array:2 [ "nombre" => "Sofia" "apellidos" => "Rosado Julião" ] 2 => array:2 [ "nombre" => "Mariana" "apellidos" => "Alves" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255123003931?idApp=UINPBA00004E" "url" => "/08702551/0000004200000011/v1_202311030625/S0870255123003931/v1_202311030625/en/main.assets" ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Reply to Letter to the Editor “Ischemic stroke and homocysteine: To test or not to test?”" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "933" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Roberto Palma Reis" "autores" => array:1 [ 0 => array:3 [ "nombre" => "Roberto" "apellidos" => "Palma Reis" "email" => array:1 [ 0 => "palma.reis@nms.unl.pt" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Serviço Cardiologia, Hospital Pulido Valente, Centro Hospitalar Lisboa Norte, Lisboa, Portugal" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Resposta a carta ao Editor «AVC isquémico e homocisteinemia: testar ou não estar?»" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">In response to the Editorial Comment “Homocysteinemia and vascular disease: where we stand in 2022”, recently published in the <span class="elsevierStyleItalic">Journal</span>,<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">1</span></a> Laura Guerreiro, Sofia Rosado Julião and Mariana Alves present a Letter to the Editor entitled “Ischemic stroke and homocysteine: to test or not to test?”<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">In general, this letter agrees with the main positions of the editorial,<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">1</span></a> pointing out that, according to the VITATOPS trial, the impact of lowering homocysteine was very low in preventing cardiovascular events and that treatment with vitamin B supplements was of dubious benefit in preventing major vascular events.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Guerreiro et al.’s letter also discusses the usefulness of testing homocysteinemia.</p><p id="par0020" class="elsevierStylePara elsevierViewall">According to the authors, in their center assessment of homocysteine levels is limited to patients included in the ‘Stroke in young patients’ protocol or for research purposes.</p><p id="par0025" class="elsevierStylePara elsevierViewall">This raises an important question that deserves consideration: when to seek new, less tested, or minor risk factors?</p><p id="par0030" class="elsevierStylePara elsevierViewall">It makes sense to look for rare causes or minor risk factors when there are no common causes or major risk factors that can explain the clinical situation.</p><p id="par0035" class="elsevierStylePara elsevierViewall">In the absence of very high previous cardiovascular risk, young patients with stroke constitute a population that, in my opinion, justifies a wider assessment, in particular looking for infrequent causes of the disease. In these circumstances, I agree with the idea of testing homocysteine levels in young patients with stroke. These patients should probably also be tested for other rare conditions with a procoagulant effect, such as protein S or protein C deficiency, as well as excluding antiphospholipid syndrome.</p><p id="par0085" class="elsevierStylePara elsevierViewall">However, in my view, assessment of homocysteine and of other minor or dubious risk factors should not be limited to young patients.</p><p id="par0040" class="elsevierStylePara elsevierViewall">In the secondary prevention of atherosclerotic disease at whatever age, I suggest homocysteine should be assessed shortly after diagnosis when conventional risk factors cannot explain the disease. This logical opinion is supported by the data presented in Guerreiro et al.’s letter, in which the percentage of homocysteine levels above cutoff is greatest in the oldest group analyzed (in the group aged 60 to 65 years, two-thirds presented homocysteine above the cutoff).</p><p id="par0090" class="elsevierStylePara elsevierViewall">In medium- and long-term follow-up, I suggest looking for other causes if, after appropriate medication and control of known factors, the patient suffers repeated major atherosclerotic events.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Appropriately medicated patients who suffer repeated ischemic events after successful percutaneous coronary intervention are a good example of the need to go further in their assessment.</p><p id="par0100" class="elsevierStylePara elsevierViewall">To conclude, I generally agree with Guerreiro et al.’s letter that there is no indication for universal homocysteine testing and that this assessment should be limited to certain groups, of which younger patients with stroke are one. In my view, testing homocysteine levels can also benefit patients with severe atherosclerotic disease not explained by conventional risk factors and, in the follow-up, homocysteine assessment can help patients with repeated atherosclerotic complications, after following the best practice to control their known and proved prognostic factors.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflicts of interest</span><p id="par0065" class="elsevierStylePara elsevierViewall">The author has no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflicts of interest" ] 1 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib0020" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Homocysteinemia and vascular disease: where we stand in 2022" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R. Palma Reis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.repc.2022.06.005" "Revista" => array:6 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "2022" "volumen" => "41" "paginaInicial" => "821" "paginaFinal" => "822" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/36210588" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0025" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Ischemic stroke and homocysteine: to test or not to test?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L. Guerreiro" 1 => "S. Rosado Julião" 2 => "M. Alves" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Rev Port Cardiol" "fecha" => "2023" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0030" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "VITATOPS, the VITAmins TO Prevent Stroke Trial: rationale and design of a randomised trial of B-vitamin therapy in patients with recent transient ischaemic attack or stroke (NCT00097669) (ISRCTN74743444)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "VITATOPS Trial Study Group" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1747-4949.2007.00111.x" "Revista" => array:6 [ "tituloSerie" => "Int J Stroke" "fecha" => "2007" "volumen" => "2" "paginaInicial" => "144" "paginaFinal" => "150" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18705976" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/08702551/0000004200000011/v1_202311030625/S0870255123003967/v1_202311030625/en/main.assets" "Apartado" => array:4 [ "identificador" => "93494" "tipo" => "SECCION" "pt" => array:2 [ "titulo" => "Letter to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "pt" ] "PDF" => "https://static.elsevier.es/multimedia/08702551/0000004200000011/v1_202311030625/S0870255123003967/v1_202311030625/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0870255123003967?idApp=UINPBA00004E" ]
Ano/Mês | Html | Total | |
---|---|---|---|
2024 Novembro | 9 | 9 | 18 |
2024 Outubro | 35 | 26 | 61 |
2024 Setembro | 38 | 24 | 62 |
2024 Agosto | 41 | 30 | 71 |
2024 Julho | 34 | 26 | 60 |
2024 Junho | 22 | 22 | 44 |
2024 Maio | 33 | 23 | 56 |
2024 Abril | 27 | 24 | 51 |
2024 Maro | 27 | 16 | 43 |
2024 Fevereiro | 26 | 23 | 49 |
2024 Janeiro | 24 | 19 | 43 |
2023 Dezembro | 38 | 33 | 71 |
2023 Novembro | 119 | 98 | 217 |
2023 Outubro | 30 | 18 | 48 |
2023 Setembro | 37 | 45 | 82 |
2023 Agosto | 0 | 2 | 2 |